KRAS, one gene present in some cancers, was considered “undruggable” for years.[1] Mutated KRAS is an important target for patients with non-small cell lung cancer (NSCLC) because it’s present in 20-25% of cases.[2] Finally, one drug, sotorasib (Lumakras), is approved to treat one mutant form of KRAS gene, KRAS G12C.[3] This mutation appears in...
Read More
Home »
next-generation sequencing
next-generation sequencing Posts on Medivizor
To receive all the
cutting-edge updates personally relevant to you
(free and private)
Categories
- Benign prostatic hyperplasia
- Blog
- Breast cancer
- Colorectal cancer
- Coronary artery disease
- Coronavirus / COVID-19
- Diabetes mellitus
- Erectile dysfunction
- Hodgkin's lymphoma
- Hypertension
- Infertility
- Kidney stones
- Leukemia
- Lung cancer
- Lymphoma
- Melanoma
- Men's Health
- Mental Health
- Multiple Myeloma
- Nocturia
- Non-Hodgkin lymphoma
- Overactive bladder
- Parkinson's Disease
- Prostate cancer
- Rheumatoid Arthritis
- Stroke
- Urinary incontinence
- Urinary tract infection
Recent Posts
- The Surprising Link Between Fat and Prostate Cancer
- Evaluating a double dose of tamsulosin in the management of patients with BPH not responding to standard tamsulosin treatment
- Benefits of Comprehensive Biomarker Testing for Lung Cancer
- It’s Not “Only” Hair: Scalp Hair Loss
- Evaluating the effectiveness of a supplement with L-arginine and Pycnogenol for men with erectile dysfunction